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Hellyver et al reported one year ago, an interesting case of
Gorham-Stout Disease (GSD) in a young female during
pregnancy.1 This case report helped us to manage a similar
complex case of a young woman who presented an acute
onset of GSD in the 25th pregnancy week with unilateral
lung involvement. This rare lymphatic disorder generally
occurs in children or young adults with no predilection of
sex.2,3 It is generally associated with vanishing bone osteo-
lytic lesions, and thoracic and abdominal involvement with
diffuse pulmonary lymphangiomatosis.2 Chylous effusions
and chylothorax, consequent to the abnormal proliferation of
lymphatic vessels may induce respiratory failure with a high
mortality risk.4–6 Extrapulmonary alterations may include
chylous ascites, lymphopenia, and destructing bone disease
for overgrowth of lymphatic vessels.4–7 The pathogenesis of
the disease is unclear and the prognosis is related to disease
localizations. The therapeutic approach to this rare disease
includes surgical procedures (such as thoracic duct ligation
for chylothorax, drainages, etc.), support therapies (such as
albumin transfusion, oxygen therapy, low-fat medium-chain
triglyceride diets), and pharmacological approaches (tamox-
ifen, interferon-α, radiation, systemic steroids, hormones,
oncologic drugs, somatostatin, bevacizumab, and sirolimus);
however, no drug has been correctly validated until
now.3,7–12 Bilateral lung transplantation can be a therapeutic
option in selected cases.11
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Abstract Gorham-Stout Disease (GSD) is a rare lymphatic disorder affecting children or young
adults with no predilection of sex. It is generally associated with vanishing bone
osteolytic lesions, thoracic and abdominal involvement, and diffuse pulmonary
lymphangiomatosis. Chylous effusions and chylothorax, consequent to the abnormal
proliferation of lymphatic vessels, may induce respiratory failure with a high mortality
risk. Extrapulmonary alterations may include chylous ascites, lymphopenia, and
destructing bone disease for overgrowth of lymphatic vessels. Here, we report the
case of a young woman who developed a severe and recalcitrant GSD with persistent
unilateral chylothorax during pregnancy. The complex management of this patient
during and after pregnancy was discussed and compared with literature data to
contribute to the definition of a correct diagnostic and therapeutic approach to this
rare lymphatic disease.
received
March 5, 2017
accepted after revision
September 12, 2017
DOI https://doi.org/
10.1055/s-0037-1615259.
ISSN 2157-6998.
Copyright © 2017 by Thieme Medical
Publishers, Inc., 333 Seventh Avenue,
New York, NY 10001, USA.
Tel: +1(212) 584-4662.
Case Report
THIEME
e226
Case Presentation
Here, we report the case of a young womanwho developed a
severe and recalcitrant GSD with persistent unilateral chy-
lothorax during pregnancy. The complexmanagement of this
patient during and after pregnancy was discussed and com-
pared with literature data to contribute to the definition of a
correct diagnostic and therapeutic approach to this rare
disease. A 32-year-old Africanwoman, in her 25th pregnancy
week, was admitted to our hospital referring acute dyspnea
at rest and severe nocturnal orthopnea. The patient had no
fever or cough but she referred acute chest pain. She already
had three previous pregnancies without complications.
Because of the dyspnea persistence and the abolition of
left lung breath sound on physical examination, a chest
X-ray was performed revealing left pleural effusion. The
thoracentesis allowed the drainage of 1900 cc of a milky
fluid. The pleural fluid analysis consisted of chylothorax, that
unfortunately continued to re-form (more than 700 ml/day),
requiring maintenance of the drainage. An interdisciplinary
meeting involving also the gynecologists was organized to
take a therapeutic decision, as the risk of surgery in that
phase of pregnancy was too high as well as the introduction
of immunosuppressive pharmacological drugs (at high risk
for the fetus). In the 30th pregnancy week, ultrasounds
revealed an intrauterine growth retardation with flowmeter
alterations. Thus, a caesarean delivery was performed and a
1.8 kg baby girl was born. Placenta histology revealed mini-
mal focal inflammation of the membranes with numerous
vessel ectasia of the chorionic villi. The patient continued to
discharge abundant milky fluid from her drainage, and
postpartum highresolution CT scans of the chest and abdo-
men were performed, revealing diffuse interlobular and
peribronchial septal thickening with left pleural effusion,
no mediastinal lymph node enlargement, but several med-
iastinal cysts (►Figs. 1–4). The liver appeared enlarged,
multiple cystic areas were observed in the spleen, and
abundant fluid groundwater was observed in the pelvic
cavity and perirenal areas. Multiloculated fluid density cysts
in lomboaortic region were observed, as well as rarefaction
lesions of sternum and D12 vertebra. Antinuclear autoanto-
bodies were positive although, rheumatologic consultation
did not reveal abnormalities; blood quantiferon and micro-
biological cultures were negative as well as all serological
biomarkers of infection and albumin concentrations in
serum were low. Unfortunately, the patient continued to
be tachypneic and tachycardic. The treatment strategy for
pleural effusion was established. Video-assisted thoraco-
scopic surgery (VATS) was performed for diagnostic reason
to do parietal pleural biopsies, and for therapeutic purposes
to perform talc pleurodesis with scarification. But the
patient continued to deteriorate requiring further surgical
approach for lung decortication and diaphragmatic plication.
This last procedure was performed because the chylous was
sparing from diaphragmatic pleurocysts (resembling lym-
phangiomas) that were biopsied. The patient fasted for
10 days after surgery receiving only total parenteral nutri-
tion with a < 5 g oral fat diet followed by a low-fat
medium-chain triglyceride diet and octreotide injections.
Microscopic examination showed extensive acute and
chronic inflammation of parietal and diaphragmatic pleura
with giant cells and proliferative lymphatic channels
with angioectasia and without cytological atypia. Reactive
mesothelial hyperplasia was described, immunohistochem-
istry for calretinin, CK7, CK5/6, Estrogen Receptor (ER) and
Progesterone Receptor (PR) testing was performed, and
lymphatic vessels alterations were documented. The patient
Fig. 1 Small lytic lesions of the vertebra (D12), pelvis (right iliac wing), and stern um.
Fig. 2 Multiloculate cystic fluid density mass (lymphangiomas) in the
anterior mediastinum.
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was dischargedwith a diagnosis of GSD. Actually, she is alive,
she has had a healthy daughter but she needs specific
treatments such as steroids, low-fat medium-chain fat diet,
and anti-inflammatory drugs for the persistence of dyspnea,
chest pain, and minimal pleural effusion.
Discussion
The features of this case include the onset of GSD during
pregnancy, and the unilateral chylothorax consequent to
thoracic vertebrae and sternum involvement. In this preg-
nant patient, the lymphatic invasion into the pleural cavity
seems to be induced by bone GSD involvement, hormonal
stimuli, and by the increase of intra-abdominal pressure
associated with chylous ascites. The hormonal stimuli may
have had a role as the patient was in the 25th pregnancy
week of her fourth pregnancy when she developed GSD,
analogously to a similar case published in your journal.1 The
main difference was that in the already published case, a
prenatal diagnosis of GSD was done many years ago and the
woman developed an acute disease phase, with severe
recalcitrant chylothorax during the fourth pregnancy week;
she was treated using a more conservative approach com-
pared to our patient, as the chylothorax was discovered at
the beginning of the pregnancy.1 Hellyver and coauthors
wondered about the possibility that female hormones pro-
duced during pregnancy can trigger this exacerbation.1,12
Perhaps, our case supports the suspicion that pregnancymay
trigger chylothorax in GSD together with changes in
intrathoracic pressure, as suggested for idiopathic chy-
lothorax occurring during pregnancy.10,12–15 No pathoge-
netic studies have been performed to verify the potential role
of estrogens in lymphatic alterations and bone cellular
metabolism occurring in GSD during pregnancy.1 In our
patient as well as in the one previously described, low oral
fat diet together with total parenteral nutrition gave positive
effects, while octreotide therapy proved ineffective only in
our patient and not in the other cases.1,12–15
In conclusion, the present case study illustrates an unusual
presentation of GSD during pregnancy underlining the diffi-
culties in the management of this disease to guaranty good
fetal and mother evolution. Further studies are required to
improve the limited therapeutic options of this rare disease.
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